Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase
dc.contributor.author | Miller, Andrew Todd | |
dc.contributor.author | Berg, Leslie J. | |
dc.date | 2022-08-11T08:09:02.000 | |
dc.date.accessioned | 2022-08-23T16:15:56Z | |
dc.date.available | 2022-08-23T16:15:56Z | |
dc.date.issued | 2002-02-23 | |
dc.date.submitted | 2008-11-21 | |
dc.identifier.citation | <p>J Immunol. 2002 Mar 1;168(5):2163-72.</p> | |
dc.identifier.issn | 0022-1767 (Print) | |
dc.identifier.doi | 10.4049/jimmunol.168.5.2163 | |
dc.identifier.pmid | 11859102 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/34210 | |
dc.description.abstract | The Tec family tyrosine kinase, IL-2-inducible T cell kinase (Itk), plays an important role in TCR signaling. Studies of T cells from Itk-deficient mice have demonstrated that Itk is critical for the activation of phospholipase-Cgamma1, leading to calcium mobilization in response to TCR stimulation. This biochemical defect results in reduced IL-2 production by Itk-deficient T cells. To further characterize the downstream effects of the Itk deficiency, we crossed Itk-/- mice to a TCR-transgenic line and examined T cell responses to stimulation by peptide plus APC. These studies show that Itk is required for maximal activation of early growth responses 2 and 3 and Fas ligand transcription after TCR stimulation. These transcriptional defects lead to reduced activation-induced cell death of stimulated Itk-/- T cells, both in vitro and in vivo. Together these studies define an important role for Itk in TCR signaling, leading to cytokine gene expression and activation-induced cell death. | |
dc.language.iso | en_US | |
dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11859102&dopt=Abstract">Link to article in PubMed</a></p> | |
dc.relation.url | https://doi.org/10.4049/jimmunol.168.5.2163 | |
dc.title | Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase | |
dc.type | Journal Article | |
dc.source.journaltitle | Journal of immunology (Baltimore, Md. : 1950) | |
dc.source.volume | 168 | |
dc.source.issue | 5 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/gsbs_sp/867 | |
dc.identifier.contextkey | 670714 | |
html.description.abstract | <p>The Tec family tyrosine kinase, IL-2-inducible T cell kinase (Itk), plays an important role in TCR signaling. Studies of T cells from Itk-deficient mice have demonstrated that Itk is critical for the activation of phospholipase-Cgamma1, leading to calcium mobilization in response to TCR stimulation. This biochemical defect results in reduced IL-2 production by Itk-deficient T cells. To further characterize the downstream effects of the Itk deficiency, we crossed Itk-/- mice to a TCR-transgenic line and examined T cell responses to stimulation by peptide plus APC. These studies show that Itk is required for maximal activation of early growth responses 2 and 3 and Fas ligand transcription after TCR stimulation. These transcriptional defects lead to reduced activation-induced cell death of stimulated Itk-/- T cells, both in vitro and in vivo. Together these studies define an important role for Itk in TCR signaling, leading to cytokine gene expression and activation-induced cell death.</p> | |
dc.identifier.submissionpath | gsbs_sp/867 | |
dc.contributor.department | Department of Pathology | |
dc.contributor.department | Morningside Graduate School of Biomedical Sciences | |
dc.source.pages | 2163-72 |